首页> The Journal of Infectious Diseases> Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phasing Out Stavudine

Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phasing Out Stavudine

导出原文传递

翻译打印收藏纠错

第一作者： Michele W. Tang

作者： Michele W. Tang ^[1] ; Soo-Yon Rhee ; Silvia Bertagnolio ; Nathan Ford ; Susan Holmes ; Kim C. Sigaloff ; Raph L. Hamers

作者单位： Division Infectious Diseases, Department of Medicine, Stanford University, California ^[1]

关键词 HIV-1 drug resistance mutations nucleoside reverse transcriptase inhibitor NRTI stavudine d4T zidovudine AZT tenofovir TDF subtypes.

发布时间 2018-06-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The Journal of Infectious Diseases

2013年207卷Suppl.2期

S70-S77页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

The Journal of Infectious Diseases

2013年207卷Suppl.2期

S70-S77页

检索历史清除

Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phasing Out Stavudine

The Journal of Infectious Diseases

相似文献

同项目论文

The Journal of Infectious Diseases

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phasing Out Stavudine

The Journal of Infectious Diseases

相似文献

同项目论文

The Journal of Infectious Diseases

相关期刊

检索历史清除